Technical analyst Kush Bohra has identified three high-conviction trading opportunities for the upcoming market session, highlighting stocks from the financial services, healthcare technology, and specialty chemicals sectors.
The analyst remains bullish on Aditya Birla Capital, IKS Health, and Navin Fluorine, citing favourable technical setups and momentum indicators that could drive near-term gains.
Here is a detailed look at the recommended trades, including entry rationale, target prices, and stop-loss levels.
Aditya Birla Capital: Bullish Momentum Seen in Financial Services Stock
Bohra believes Aditya Birla Capital is showing encouraging signs of strength on the charts and could continue its upward trajectory in the coming sessions.
The stock has been witnessing positive momentum, and the analyst expects buying interest to remain intact as long as it sustains above key support levels.
Trading Strategy for Aditya Birla Capital
- Target 1: Rs 406
- Target 2: Rs 419
- Stop Loss: Rs 383
According to Bohra, the stock offers an attractive risk-reward profile for short-term traders looking to capitalize on momentum in the financial services segment.
IKS Health: Healthcare Technology Stock Remains Technically Strong
In the healthcare technology space, IKS Health continues to display a robust technical structure, making it one of Bohra’s preferred picks.
The stock has maintained a positive trend and could witness further upside if current momentum persists.
Trading Strategy for IKS Health
- Target 1: Rs 1,800
- Target 2: Rs 1,880
- Stop Loss: Rs 1,640
Bohra expects the stock to extend its gains over the near term, with traders advised to maintain strict stop-loss discipline to manage risk.
Navin Fluorine: Specialty Chemicals Stock Offers Upside Potential
Among specialty chemical companies, Navin Fluorine International has emerged as another technically attractive opportunity.
The analyst believes the stock’s chart pattern supports further upside movement, with buyers likely to remain active at current levels.
Trading Strategy for Navin Fluorine
- Target: Rs 7,950
- Stop Loss: Rs 7,575
The stock remains one of Bohra’s preferred plays within the specialty chemicals sector due to its favourable technical positioning and potential breakout prospects.
Focus on Risk Management
While all three stocks present positive technical setups, market participants are advised to follow the recommended stop-loss levels strictly to protect capital in case of unexpected market volatility.
Analysts also caution that technical recommendations are intended for short-term trading purposes and should be evaluated alongside broader market conditions and individual risk appetite.
Disclaimer
The stock recommendations and views mentioned above are those of technical analyst Kush Bohra and do not necessarily reflect the views of this publication. Investors should consult a qualified financial advisor before making any investment decisions. Equity markets are subject to risk, and past performance is not indicative of future returns.